Funding Pharmacology & Personalised Medicine
Current Funding
| Project | Funding Source |
Amount (m€) |
Period | Role of the PI |
|---|---|---|---|---|
| H2020 FeatureCloud | EU | 0.28 | 2018-2023 | Co-PI |
| H2020 REPO-TRIAL | EU | 5.6 | 2018-2023 | Co-PI |
| H2020 ERC PoC: SAVEBRAIN | EU | 0.15 | 2017-2018 | PI |
| EU COST Action 15120 OpenMultiMed | EU |
2016-2020 |
Chair | |
| Confidential | BayerHealthcare | 0.25 | 2016-2018 | PI |
| Confidential | Boehringer-Ingelheim | 0.06 | 2013 | PI |
| Confidential | Servier | 0.25 | 2013 | PI |
| Confidential | Abbott | 0.15 | 2013 | PI |
Previous Funding
| Project | Funding Source | Amount (m€) | Period | Role of the PI |
|---|---|---|---|---|
| H2020 Marie Curie International Reintegration Grant | EU | 0.1 | 2011-2014 | PI |
| EU COST Action: Gasotransmitters | EU |
0.09 |
2011-2013 | Co-PI |
| Innovation Grant | Nierstichting | 0.1 |
2012-2014 |
PI |
| ERC AdG | EU | 2.3 |
2012-2016 |
PI |
| EU COST Action: EU-ROS | EU |
0.16 |
2012-2016 | Co-PI |
| NOX4IS | EUROSTARS | 0.8 |
2014-2016 |
Co-PI |
| H2020 ERC AdG: RadMed | EU | 2.5 |
2011-2017 |
PI |
| Hersenstichting | PI | |||
| NHMRC |
Co-PI |
* Grants of Prof. Harald Schmidt before he joined Maastricht University are not inluded.